Lv5
968 积分 2023-01-09 加入
Kawase’s Education Day: An Iconic Instance of a Surgical Approach Evolution
3天前
已完结
BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it
24天前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
27天前
已完结
Targeting RET alterations in non-small cell lung cancer
27天前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
27天前
已完结
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance
30天前
已完结
The past, present, and future of ALK-targeted drug discovery
30天前
已完结
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
30天前
已关闭
Progression and Expansion of ALK Inhibitors Against NSCLC: A Dual Target Approach
30天前
已完结
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
1个月前
已完结
皖公网安备34019202002308
